Skip to main content

Published locations for Overall Survival Gain With Adding Darolutamide to ADT and Docetaxel in Metastatic, Hormone-Sensitive Prostate Cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Overall Survival Gain With Adding Darolutamide to ADT and Docetaxel in Metastatic, Hormone-Sensitive Prostate Cancer

User login

  • Reset your password
  • /content/overall-survival-gain-adding-darolutamide-adt-and-docetaxel-metastatic-hormone-sensitive
  • /jcomjournal/article/255042/oncology/overall-survival-gain-adding-darolutamide-adt-and-docetaxel